Skip to main content

Celiac Disease, Wheat Allergy and Gluten Intolerance: What's the Difference?

Celiac disease, gluten intolerance, and wheat allergy are the three major disorders that are known to trigger unpleasant symptoms following intake of foods made using wheat. Although the three conditions share similar symptoms, their pathogenic mechanism, diagnosis and treatment are quite different. Coeliac disease is permanent, whereas allergies and intolerances can come and go during a person’s life. 

Celiac disease is a genetic, autoimmune disorder that occurs in reaction to the ingestion of gluten, a protein found in wheat, barley, and rye. The reaction to gluten causes inflammation and atrophy of intestinal lining, which can lead to malabsorption of nutrients and related health issues.
The diagnosis of Celiac disease is classically based on a combination of findings from a patient’s clinical history, serologic testing (anti-transglutaminase IgA antibody, anti-endomysium antibody, Deamidated Gliadin Peptide) and duodenal biopsies.

Wheat allergy is an immune reaction (IgE mediated) to a number of food proteins found in wheat, including gluten. However, unlike celiac disease, this immune response is most often temporary. 
The diagnosis of Wheat allergy is classically based on skin prick tests (SPT), in vitro specific Immunoglobulin E assays (Blood allergy test). 

Gluten intolerance, also known as non-celiac gluten sensitivity, the condition of people who cannot tolerate gluten in their food and experience similar symptoms to celiac disease, but without the same kind of intestinal damage as occurs in coeliac cases. . 
Gluten intolerance is mainly a “diagnosis of exclusion” made after other wheat-related and non-wheat-related disorders have been ruled out. 


 

Comments

Popular posts from this blog

Diagnosis of Celiac disease

Coeliac disease is an autoimmune disease where the lining of the small intestine is damaged by exposure to gluten (a protein found in grains such as wheat, rye, barley and oats) in genetically predisposed children and adults. The reaction to gluten causes inflammation and atrophy of intestinal lining, which can lead to malabsorption of nutrients and related health issues. The diagnosis of Celiac disease is classically based on a combination of findings from a patient’s clinical history, serologic testing and duodenal biopsies. SEROLOGY TEST: Serologic tests are for screening purposes and do not confirm the diagnosis of coeliac disease. Serologic tests for celiac disease include anti-transglutaminase IgA & IgG antibody, anti-endomysium IgA antibody, and Deamidated Gliadin Peptide IgA & IgG antibodies.  The serologic tests that check for IgA antibodies are more sensitive for celiac disease than the tests for IgG antibodies. However, in people who have IgA deficiency, IgG tests ma

Hepatitis Markers

  Hepatitis means inflammation of the liver. It is commonly the result of a viral infection (hepatitis viruses A, B, C, D, and E), but there are other possible causes of hepatitis like autoimmune hepatitis and hepatitis that occurs as a secondary to medications, drugs, toxins, and alcohol. Hepatitis markers (Antigens, Antibodies & PCR) are useful for determining diagnosis, appropriate treatment, and vaccination status and for monitoring treatment.  Viral Hepatitis Markers: Hepatitis A virus-IgM Antibodies (anti-HAV IgM) : Serum IgM antibody to the hepatitis A virus (antiHAV) appears at about four weeks after initial infection and usually persists for 2-6 months as the initial phase of the immune response. (Test code H018) Hepatitis A virus-IgG Antibodies (anti-HAV IgG) : Serum IgG antibody to HAV generally persists for lifetime, conferring immunity to further HAV infection. (Test code H017) Hepatitis A virus-Total Antibodies (Anti-HAV-Total Ab) : The total HAV antibody test detect

Mucorales RT-PCR: A potential game changer in diagnosis of Mucormycosis

Mucormycosis refers to severe infectious diseases that are caused by filamentous fungi of the Mucorales order that primarily affect immunocompromised patients and patients with diabetes mellitus. Recently, an increasing incidence has been reported among COVID-19 patients in India. The most common genera in invasive mucormycosis are Rhizopus, Rhizomucor, Lichtheimia and Mucor, accounting for 90% of all cases. Clinically and radiographically, mucormycosis is often indistinguishable from other invasive fungal infections such as aspergillosis and remains difficult to diagnose. A definitive diagnosis of mucormycosis typically requires histopathological evidence or positive fungal culture from a specimen from the site of infection, which may be difficult to obtain in some patients. A molecular diagnostic approach, detecting circulating DNA of Mucorales (by PCR) in serum of patients, may help to diagnose invasive mucormycosis more quickly and to introduce directed therapy earlier and eventual

Am